Overview

Welcome to Dwaey, specifically on COMPIFY 1mg/ml SOlution (Oral) page.
This medicine contains an important and useful components, as it consists of Aripiprazole.
COMPIFY 1mg/ml is available in the market in concentration 1mg/ml and in the form of SOlution (Oral).

FARMOZ Ð SOCIEDADE TƒCNICO-MEDICINAL, S.A is the producer of COMPIFY 1mg/ml and it is imported from PORTUGAL, The most popular alternatives of COMPIFY 1mg/ml are listed downward .

Mode Of Action & Indication

Aripiprazole acts as a partial agonist at D2 and 5-HT1A receptors and as an antagonist at 5-HT2A receptors.

Indication

• Major depressive disorder
• Schizophrenia
• Acute manic episodes of bipolar disorder
• Agitation
• Irritability in autism

Precaution

Patients with known CV diseases (e.g. history of MI, IHD, CCF or conduction abnormalities), cerebrovascular diseases or conditions which would predispose patients to hypotension; Alzheimer's disease and dementia. Caution when operating hazardous machinery, including automobiles when taking aripiprazole. Pregnancy. Lactation: Excreted in human breast milk; a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother

Side Effects

• >10% Weight gain (8-30%)
• Headache (27%)
• Agitation (19%)
• Insomnia (18%)
• Anxiety (17%)
• Nausea and vomiting (11-15%)
• Akathisia (10-13%)
• Lightheadedness (11%)
• Constipation (10-11%) 1-10% Dizziness (10%)
• Dyspepsia (9%)
• Somnolence (5-8%)
• Fatigue (6%)
• Restlessness (6%)
• Tremor (6%)
• Dry mouth/xerostomia (5%)
• Extrapyramidal disorder (5%)
• Orthostatic hypotension (1-5%)
• Musculoskeletal stiffness (4%)
• Abdominal discomfort (3%)
• Blurred vision (3%)
• Cough (3%)
• Pain (3%)
• Myalgia (2%)
• Rash
• Rhinitis <1% Altered mental status
• Autonomic instability
• Dysphagia
• Hyperpyrexia
• Muscle rigidity
• Neuroleptic malignant syndrome (NMS)
• Seizure
• Tardive dyskinesia

Contra indication

Hypersensitivity. Lactation. Children <18 yr.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks